College of Marine Life Science, Ocean University of China, Qingdao, People's Republic of China.
J Mater Sci Mater Med. 2012 Feb;23(2):375-84. doi: 10.1007/s10856-011-4470-9. Epub 2011 Dec 3.
Oleoyl-carboxymethy chitosan (OCMCS) nanoparticles based on chitosan with different molecular weights (50, 170 and 820 kDa) were prepared by self-assembled method. The nanoparticles had spherical shape, positive surface charges and the mean diameters were 157.4, 274.1 and 396.7 nm, respectively. FITC-labeled OCMCS nanoparticles were internalized via the intestinal mucosa and observed in liver, spleen, intestine and heart following oral deliverance to carps (Cyprinus carpio). Extracellular products (ECPs) of Aeromonas hydrophila as microbial antigen was efficiently loaded to form OCMCS-ECPs nanoparticles and shown to be sustained release in PBS. Significantly higher (P < 0.05) antigen-specific antibodies were detected in serum after orally immunized with OCMCS-ECPs nanoparticles than that immunized with ECPs alone and non-immunized in control group in carps. These results implied that amphiphilic modified chitosan nanoparticles had great potential to be applied as carriers for the oral administration of protein drugs.
基于相对分子质量分别为 50、170 和 820 kDa 的壳聚糖,通过自组装法制备了油酰羧甲基壳聚糖(OCMCS)纳米粒。纳米粒呈球形,带正电荷,平均粒径分别为 157.4、274.1 和 396.7nm。FITC 标记的 OCMCS 纳米粒经肠道黏膜内化,并在口服给予鲤鱼(Cyprinus carpio)后在肝脏、脾脏、肠道和心脏中观察到。将气单胞菌的胞外产物(ECPs)作为微生物抗原有效负载形成 OCMCS-ECPs 纳米粒,并在 PBS 中显示出持续释放。与单独免疫 ECPs 组和对照组相比,经 OCMCS-ECPs 纳米粒口服免疫的鲤鱼血清中检测到更高水平的抗原特异性抗体(P < 0.05)。这些结果表明,两亲性改性壳聚糖纳米粒具有作为蛋白质药物口服给药载体的巨大潜力。